These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate. Bierbach U; Sabat M; Farrell N Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro. Kratochwil NA; Zabel M; Range KJ; Bednarski PJ J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447 [TBL] [Abstract][Full Text] [Related]
4. Preparation of platinum(II) complexes with L-serine using KI. X-ray crystal structure, HPLC and 195Pt NMR spectra. Watabe M; Kai M; Goto K; Ohmuro H; Furukawa S; Chikaraishi N; Takayama T; Koike Y J Inorg Biochem; 2003 Oct; 97(2):240-8. PubMed ID: 14512203 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2]. Shamsuddin S; Santillan CC; Stark JL; Whitmire KH; Siddik ZH; Khokhar AR J Inorg Biochem; 1998 Aug; 71(1-2):29-35. PubMed ID: 9755489 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation. Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and antitumor activity of novel octahedral Pt(IV) complexes. Kwon YE; Whang KJ; Park YJ; Kim KH Bioorg Med Chem; 2003 Apr; 11(8):1669-76. PubMed ID: 12659753 [TBL] [Abstract][Full Text] [Related]
8. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O. Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2]. Ali Khan SR; Huang S; Shamsuddin S; Inutsuka S; Whitmire KH; Siddik ZH; Khokhar AR Bioorg Med Chem; 2000 Mar; 8(3):515-21. PubMed ID: 10732967 [TBL] [Abstract][Full Text] [Related]
11. Accurate prediction of 195Pt NMR chemical shifts for a series of Pt(II) and Pt(IV) antitumor agents by a non-relativistic DFT computational protocol. Tsipis AC; Karapetsas IN Dalton Trans; 2014 Apr; 43(14):5409-26. PubMed ID: 24519094 [TBL] [Abstract][Full Text] [Related]
12. Platinum(II) catalysis and radical intervention in reductions of platinum(IV) antitumor drugs by ascorbic acid. Weaver EL; Bose RN J Inorg Biochem; 2003 Jul; 95(4):231-9. PubMed ID: 12818793 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles. Dedon PC; Borch RF Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of N-methyliminodiacetato trans-R,R-, trans-S,S-, and cis-1,2-diaminocyclohexane platinum (IV) complexes: crystal structure of chloro(trans-R,R-1,2-diaminocyclohexane) (N-methyliminodiacetato) platinum(IV) chloride. Xu Q; Khokhar AR J Inorg Biochem; 1992 Nov; 48(3):217-26. PubMed ID: 1447569 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers. Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964 [TBL] [Abstract][Full Text] [Related]
16. New antitumor-active azole-bridged dinuclear platinum(II) complexes: synthesis, characterization, crystal structures, and cytotoxic studies. Komeda S; Lutz M; Spek AL; Chikuma M; Reedijk J Inorg Chem; 2000 Sep; 39(19):4230-6. PubMed ID: 11196916 [TBL] [Abstract][Full Text] [Related]
17. Preparation, X-ray crystal structure, and 195Pt NMR spectra of platinum(II) with dipeptides and dipeptide methyl esters. Watabe M; Kai M; Hayashi M; Kamiyama K; Okada H; Takayama T J Inorg Biochem; 2000 Jul; 81(1-2):49-55. PubMed ID: 11001431 [TBL] [Abstract][Full Text] [Related]
18. Crystal structures and cytotoxicity of isopropylamine Pt(II) complexes: a trinuclear squarato-bridged [Pt3(mu2-C4O4)3(H2NPri)6].3H2O and a mononuclear cis-[Pt(NO3)2(H2NPri)2]. Grabner S; Modec B; Cemazar M; Bukovec N J Inorg Biochem; 2005 Jul; 99(7):1465-71. PubMed ID: 15927264 [TBL] [Abstract][Full Text] [Related]
19. Platinum(IV) complexes with dipeptide. X-ray crystal structure, 195Pt NMR spectra, and their inhibitory glucose metabolism activity in Candida albicans. Watabe M; Kai M; Asanuma S; Yoshikane M; Horiuchi A; Ogasawara A; Watanabe T; Mikami T; Matsumoto T Inorg Chem; 2001 Mar; 40(7):1496-500. PubMed ID: 11261956 [TBL] [Abstract][Full Text] [Related]